4//SEC Filing
LYONDELL CHEMICAL CO 4
Accession 0001181431-04-007352
CIK 0000842635operating
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 12:18 PM ET
Size
15.2 KB
Accession
0001181431-04-007352
Insider Transaction Report
Form 4
ENGEN D TRAVIS
Director
Transactions
- Award
Common Stock
2004-02-05+2,271→ 18,382 total - Award
Phantom Stock
2004-02-05+2,271→ 2,271 totalFrom: 2014-02-05Exp: 2014-02-05→ Common Stock (2,271 underlying) - Award
Tandem Cash Right
2004-02-05+5,000→ 5,000 totalExercise: $12.91From: 2004-02-05Exp: 2010-02-03→ Common Stock (5,000 underlying)
Footnotes (5)
- [F1]Converts on a 1 for 1 basis.
- [F2]May vest earlier under certain circumstances, including death, disability, retirement or change in control, as provided in the Restricted Stock Plan for Non-Employee Directors.
- [F3]This right was granted on 2/5/2004 as a tandem right to a previously granted stock option for the purchase of 5,000 shares at an exercise price of $12.9125 per share. Under the tandem cash right, the reporting person may, in lieu of exercising the stock option for shares, elect to receive from the Company a cash payment equal to the aggregate fair market value of the shares, upon payment to the Company of the exercise price. Accordingly, the exercise of the tandem cash right results in the expiration of the stock option and vice versa.
- [F4]This right was granted on 2/5/2004 as a tandem right to a previously granted stock option for the purchase of 5,000 shares at an exercise price of $16.25 per share. Under the tandem cash right, the reporting person may, in lieu of exercising the stock option for shares, elect to receive from the Company a cash payment equal to the aggregate fair market value of the shares, upon payment to the Company of the exercise price. Accordingly, the exercise of the tandem cash right results in the expiration of the stock option and vice versa.
- [F5]This right was granted on 2/5/2004 as a tandem right to a previously granted stock option for the purchase of 5,000 shares at an exercise price of $13.80 per share. Under the tandem cash right, the reporting person may, in lieu of exercising the stock option for shares, elect to receive from the Company a cash payment equal to the aggregate fair market value of the shares, upon payment to the Company of the exercise price. Accordingly, the exercise of the tandem cash right results in the expiration of the stock option and vice versa.
Documents
Issuer
LYONDELL CHEMICAL CO
CIK 0000842635
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000842635
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 12:18 PM ET
- Size
- 15.2 KB